Piper Jaffray Lowers Gentiva Health Services Price Target to $11.00 (GTIV)
Equities researchers at Piper Jaffray lowered their price target on shares of Gentiva Health Services (NASDAQ:GTIV) from $12.00 to $11.00 in a research report issued on Friday, StockRatingsNetwork reports. Piper Jaffray’s target price suggests a potential upside of 34.97% from the company’s current price.
Gentiva Health Services (NASDAQ:GTIV) traded up 0.87% during mid-day trading on Friday, hitting $8.15. 241,591 shares of the company’s stock traded hands. Gentiva Health Services has a 52 week low of $7.35 and a 52 week high of $13.85. The stock has a 50-day moving average of $8.30 and a 200-day moving average of $10.60. The company’s market cap is $299.6 million.
Gentiva Health Services (NASDAQ:GTIV) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.11 by $0.02. The company had revenue of $487.50 million for the quarter, compared to the consensus estimate of $491.51 million. During the same quarter last year, the company posted $0.23 earnings per share. Gentiva Health Services’s revenue was up 17.3% compared to the same quarter last year. Analysts expect that Gentiva Health Services will post $0.88 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at CRT Capital initiated coverage on shares of Gentiva Health Services in a research note on Tuesday, April 8th. They set a “buy” rating and a $10.50 price target on the stock. They noted that the move was a valuation call. Analysts at Zacks downgraded shares of Gentiva Health Services from an “outperform” rating to an “underperform” rating in a research note on Thursday, March 20th. They now have a $8.25 price target on the stock. Four investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $10.79.
Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.